Cambridge, UK, 30 October 2018 – Microbiotica, a leading player in microbiome-based therapeutics, today announced that it will join the microbiome panel at this year’s BIO-Europe®, taking place in Copenhagen between 5-7 November.
Mike Romanos, CEO of Microbiotica, will participate in the Microbiome and the Implication on Other Therapeutic Areas along with panellists from Enterome, Ferring Pharmaceuticals, Health Opportunities GmbH, Sorbonne University and Seventure Partners, Microbiotica’s newest investor. The panel will take place in Room C2 between 1.30-2.30pm on Monday 5 November.
The BIO-Europe 2018 partnering event is expected to draw over 4,000 industry attendees for three days of high-level networking, representing more than 2,000 companies from over 60 countries.
Microbiotica has had a transformational year in 2018, signing collaborative deals with Genentech and the University of Adelaide, as well as securing additional investment.